ClinicalTrials.Veeva

Menu

Shanghai High Myopia Study

S

Shanghai High Myopia Study Group

Status

Enrolling

Conditions

Visual Outcome
Cataract
High Myopia
Genetic Anticipation

Treatments

Other: Cataract

Study type

Observational

Funder types

Other

Identifiers

NCT03062085
NSFC-81670835

Details and patient eligibility

About

The purpose of this study is to evaluate the long-term visual outcome of the cataract surgery using a large-scale and comprehensive database of high myopic cataract and age-related cataract patients. The investigators will further investigate into the various genetic and environmental factors that may contribute to the pathogenesis of high myopic cataract.

Full description

High myopic cataract (HMC) has become a major high-risky type of cataract in China, which accounts for nearly 30% of cataract in recent years. Compared to age-related cataract, HMC is characterized with earlier onset, severer lens opacities, higher incidence of vitreoretinopathy and postoperative complications compared to age-related cataract(ARC).

The main purpose of this study is to evaluate the long-term visual outcome of the cataract surgery using a large-scale and comprehensive database of high myopic cataract, when compared to those age-matched ARC patients.

On the other hand, due to the lack of research in the pathogenesis of HMC, it is difficult for the investigators to precisely evaluate its risk and prognosis, and to improve its prevention and treatment. The previous study of investigators majored in a large-sample analysis on the clinical features and related genes of HMC. After preliminary screening, eight genes were selected for further investigation: 1) genes related to pathogenesis of HMC: CRYAA/ GSTP1/ TXNRD2;2) genes related to vitreoretinopathy: MCP1/ VEGFA/ CFH; 3) genes related to postoperative complications: TGFB2/ CERS2. In the present study, in order to establish a risk model of HMC from the aspect of precision medicine, the investigators are preparing to set up a comprehensive clinical database for further sequencing of selected genes (including exons, promoters, 5' UTR and 3' UTR sequences) on a large scale, to intensively investigate into the sites and functions of single nucleotide polymorphism (SNP) correlated with clinical features of HMC.

The research aim to evaluate the long-term visual outcome of the cataract surgery using a large-scale and comprehensive database of high myopic cataract, to thoroughly illustrate the influence of HMC-related genes to its prognosis and to elucidate the pathogenesis of HMC, for further promotion in the disease prevention and prognosis as well.

Enrollment

60,000 estimated patients

Sex

All

Ages

20 to 100 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Clinical diagnosis of cataract
  • Must be able to cooperate with the ophthalmic examination

Exclusion criteria

  • Clinical diagnosis of mental illness
  • Mentally disabled

Trial design

60,000 participants in 3 patient groups

High myopic cataract group
Description:
Cataract patients with high myopia.
Treatment:
Other: Cataract
Age-related cataract group
Description:
Age-related cataract patients.
Treatment:
Other: Cataract
Ametropic cataract group
Description:
Cataract patients with ametropia.
Treatment:
Other: Cataract

Trial contacts and locations

1

Loading...

Central trial contact

Yi Lu, M.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems